Infective Endocarditis: Difference between revisions

Jump to navigation Jump to search

Infective Endocarditis (view source)

Revision as of 13:59, 29 November 2013

599 bytes removed ,  29 November 2013
no edit summary
No edit summary
No edit summary
Line 154: Line 154:
**Incision or biopsy of the respiratory mucosa, or procedures involving treatment of abscess of empyema
**Incision or biopsy of the respiratory mucosa, or procedures involving treatment of abscess of empyema


Antibiotic prophylaxis is also recommended for any procedures on infected skin/skin structures or musculoskeletal tissue in high risk patients.<cite>xix</cite>
Antibiotic prophylaxis is also recommended for any procedures on infected skin/skin structures or musculoskeletal tissue in high risk patients.<cite>xviii</cite>


==Complications of Endocarditis==
==Complications of Endocarditis==
Line 181: Line 181:
#x Lalani, T et al. "Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database." European Journal of Clinical Microbiology and Infectious Diseases 25.6 (2006): 365-368.
#x Lalani, T et al. "Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database." European Journal of Clinical Microbiology and Infectious Diseases 25.6 (2006): 365-368.
#xi McDonald, Jay R. "Acute infective endocarditis." Infectious disease clinics of North America 23.3 (2009): 643-664.
#xi McDonald, Jay R. "Acute infective endocarditis." Infectious disease clinics of North America 23.3 (2009): 643-664.
#xii Das, MD, M et al. "Infective endocarditis caused by HACEK microorganisms." Annual review of medicine 48.1 (1997): 25-33.
#xii pmid=9046942
#xiii Baddour, Larry M et al. "Infective Endocarditis Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America." Circulation 111.23 (2005): e394-e434.
#xiii pmid=15956145
#xiv pmid=10770721
#xiv pmid=10770721
#xv pmid=15145856
#xv pmid=15145856
Line 191: Line 191:
#xx [http://www.ncbi.nlm.nih.gov/genome/sts/sts.cgi?uid=85362 The National Center for Biotechnology Information. "UniSTS." 2006. 20 Nov. 2013]
#xx [http://www.ncbi.nlm.nih.gov/genome/sts/sts.cgi?uid=85362 The National Center for Biotechnology Information. "UniSTS." 2006. 20 Nov. 2013]
#xxi pmid=3259778
#xxi pmid=3259778
#xxii pmid=15956145
#xxii  
#xxiii pmid=22110106
#xxiii pmid=22110106
#xxiv pmid=11479467
#xxiv pmid=11479467
NiloferT
467

edits

Retrieved from "https://www.textbookofcardiology.org/wiki/Special:MobileDiff/2481"

Navigation menu